Follow
Philip Young-Ill Choi
Philip Young-Ill Choi
Haematologist, The Canberra Hospital
Verified email at act.gov.au
Title
Cited by
Cited by
Year
Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro
M Iraqi, J Perdomo, F Yan, PYI Choi, BH Chong
Haematologica 100 (5), 623, 2015
1112015
A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4)
PYI Choi, F Roncolato, X Badoux, S Ramanathan, SJ Ho, BH Chong
Blood, The Journal of the American Society of Hematology 126 (4), 500-503, 2015
852015
Rilzabrutinib, an oral BTK inhibitor, in immune thrombocytopenia
DJ Kuter, M Efraim, J Mayer, M Trněný, V McDonald, R Bird, ...
New England Journal of Medicine 386 (15), 1421-1431, 2022
782022
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
S Verstovsek, AT Gerds, AM Vannucchi, HK Al-Ali, D Lavie, ...
The Lancet 401 (10373), 269-280, 2023
762023
Recommendations for the clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia (VITT) for SARS-CoV-2 infections: communication from the ISTH …
I Nazy, UJ Sachs, DM Arnold, SE McKenzie, P Choi, K Althaus, MT Ahlen, ...
J Thromb Haemost 19 (6), 1585-1588, 2021
402021
Drug-induced immune thrombocytopenia
BH Chong, PYI Choi, L Khachigian, J Perdomo
Hematology/Oncology Clinics 27 (3), 521-540, 2013
392013
Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia
VM Chen, JL Curnow, HA Tran, PYI Choi
The Medical Journal of Australia 215 (6), 245, 2021
362021
Novel scientific approaches and future research directions in understanding ITP
SM Hicks, LA Coupland, A Jahangiri, PY Choi, EE Gardiner
Platelets 31 (3), 315-321, 2020
232020
Assessment of immunological anti‐platelet factor 4 antibodies for vaccine‐induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: A multicenter study …
EJ Favaloro, J Clifford, E Leitinger, M Parker, P Sung, S Chunilal, H Tran, ...
Journal of Thrombosis and Haemostasis 20 (12), 2896-2908, 2022
212022
Global variation in anastomosis and end colostomy formation following left‐sided colorectal resection
GlobalSurg Collaborative, Writing group, JC Glasbey, AO Adisa, ...
BJS open 3 (3), 403-414, 2019
202019
A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia
CSM Lee, HPH Liang, DE Connor, A Dey, I Tohidi-Esfahani, H Campbell, ...
Blood advances 6 (11), 3494-3506, 2022
192022
Assessment of symptom, disability, and financial trajectories in patients hospitalized for COVID-19 at 6 months
AJ Admon, TJ Iwashyna, LA Kamphuis, SJ Gundel, SK Sahetya, ID Peltan, ...
JAMA network open 6 (2), e2255795-e2255795, 2023
172023
Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand
PYI Choi, E Merriman, A Bennett, AK Enjeti, CW Tan, I Goncalves, D Hsu, ...
Medical Journal of Australia 216 (1), 43-52, 2022
172022
Immune thrombocytopenia following vaccination during the COVID-19 pandemic
PYI Choi, D Hsu, HA Tran, CW Tan, A Enjeti, VMY Chen, BH Chong, ...
Haematologica 107 (5), 1193, 2022
152022
R2 and R2* MRI assessment of liver iron content in an undifferentiated diagnostic population with hyperferritinaemia, and impact on clinical decision making
ML Craft, M Edwards, TP Jain, PY Choi
European Journal of Radiology 135, 109473, 2021
132021
Presentation and outcome of idiopathic thrombocytopenic purpura in a single Australian centre
PYI Choi, JEA Gordon, M Harvey, BH Chong
Internal Medicine Journal 42 (7), 841-845, 2012
102012
The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters
PY Choi, RF Grace, MT Ahlen, I Nazy, UJ Sachs, DM Arnold, ...
Journal of Thrombosis and Haemostasis 19 (8), 2094-2095, 2021
72021
Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
KY Lai, SY Au, KM Fong
N Engl J Med, e11-e11, 2021
72021
Updated phase I/II safety and efficacy results for oral bruton tyrosine kinase inhibitor rilzabrutinib in patients with relapsed/refractory immune thrombocytopenia
DJ Kuter, N Tzvetkov, M Efraim, Z Kaplan, J Mayer, P Choi, AJG Jansen, ...
Blood 138, 14, 2021
52021
Platelet dysfunction detected using rotational thromboelastometry (ROTEM) in severely thrombocytopenic patients with a bleeding phenotype
PYI Choi, S Hicks, EE Gardiner, P Crispin, J Slade, J D'Rozario, C Parish, ...
Blood 134, 2357, 2019
52019
The system can't perform the operation now. Try again later.
Articles 1–20